The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. “Shock, the inability to maintain blood flow to vital
FDA approves La Jolla’s low blood pressure drugReuters
La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)GlobeNewswire (press release)
The FDA just hit a record for drug approvals in a single yearSTAT

all 7 news articles …read more

Source: HEALTH